Cyclobenzaprine Hydrochloride Capsule, Extended Release
Product Images NDC 70518-4225

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hydrochloride (NDC 70518-4225). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
This is the label information for Cyclobenzaprine HCI extended-release 15 mg capsules, containing 30 capsules. The manufacturer is TWIPharmaceuticals USA located in Paramus, New Jersey. The medication should be stored at 20-25°C (58-77°F) with excursions permitted to 15-30°C (59-86°F) as per USP guidelines. The directions for use can be found in the package insert. Remember to keep this medication out of the reach of children.*
FDA Label Image

Structural Formula (Image 1)

Structural Formula (Image 1)
FDA Label Image

Image (Image 2)

Image (Image 2)
FDA Label Image

Image (Image 3)

Image (Image 3)
FDA Label Image

Image (Image 4)

Image (Image 4)
FDA Label Image

Image (Image 5)

Image (Image 5)
FDA Label Image

Image (Image 6)

Image (Image 6)
FDA Label Image

Image (Image 7)

Image (Image 7)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.